Work

Phase II trial of irinotecan plus cisplatin (IP) and etoposide plus cisplatin (EP) given weekly on alternating weeks with granulocyte colony-stimulating factor support in the treatment of extensive-stage small cell lung cancer

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.18119

Authors: J. Uyeki, F. M. Johnson, L. Feng, B. O. Peeples, G. J. Blumenschein, F. V. Fossella, D. D. Karp, K. M. Pisters, D. J. Stewart, B. S. Glisson

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2246016497

Cites:

Cited by:

Related to: 10